1. Home
  2. TLF vs MRKR Comparison

TLF vs MRKR Comparison

Compare TLF & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tandy Leather Factory Inc.

TLF

Tandy Leather Factory Inc.

HOLD

Current Price

$2.44

Market Cap

19.5M

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.50

Market Cap

22.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLF
MRKR
Founded
1980
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
22.5M
IPO Year
2006
2010

Fundamental Metrics

Financial Performance
Metric
TLF
MRKR
Price
$2.44
$1.50
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
37.0K
66.7K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
32.05%
N/A
EPS Growth
1122.22
33.61
EPS
0.03
N/A
Revenue
$76,324,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$936.27
P/E Ratio
$80.67
N/A
Revenue Growth
2.60
N/A
52 Week Low
$2.20
$0.81
52 Week High
$3.78
$4.07

Technical Indicators

Market Signals
Indicator
TLF
MRKR
Relative Strength Index (RSI) 59.20 48.38
Support Level $2.26 $1.35
Resistance Level $2.44 $1.44
Average True Range (ATR) 0.07 0.09
MACD 0.01 0.01
Stochastic Oscillator 83.39 31.71

Price Performance

Historical Comparison
TLF
MRKR

About TLF Tandy Leather Factory Inc.

Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, and Canada. it generates the highest revenue from the United States.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Share on Social Networks: